parecoxib + morphine

**Parecoxib + morphine** is a pharmaceutical combination used for short-term management of moderate to severe postoperative pain, typically as part of a multimodal analgesia regimen. Parecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor and a non-steroidal anti-inflammatory drug (NSAID) prodrug of valdecoxib, providing analgesic and anti-inflammatory effects by inhibiting prostanoid synthesis. Morphine is a classic opioid analgesic that acts primarily as a full agonist of the mu-opioid receptor in the central nervous system, providing potent pain relief through inhibition of nociceptive transmission and modulation of pain signaling. Administering the two drugs together leverages their distinct mechanisms of action, resulting in greater pain control and a morphine-sparing effect, which decreases the required dose of morphine and reduces the risk of opioid-related side effects such as respiratory depression, nausea, and vomiting. This combination is typically delivered intravenously in perioperative and postoperative settings[3][4].